Home Newsletters Daily Report PM GB Sciences Louisiana sale should not disrupt medical marijuana production

    GB Sciences Louisiana sale should not disrupt medical marijuana production

    As GB Sciences Louisiana sheds its corporate parent to be fully owned by Lafayette-based Wellcana Group, GB Sciences Louisiana President John Davis says patients shouldn’t notice a change as that th…


    Already an INSIDER? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.
    Exit mobile version